Indo US Bio-Tech Ltd (INDOUS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 541304 | NSE: INDOUS | Agriculture | Small Cap

Indo US Bio-Tech Share Price

119.40 -5.60 -4.48%
as on 18-Dec'25 16:59

DeciZen - make an informed investing decision on Indo US Bio-Tech

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Indo US Bio-Tech stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
14.84
Market Cap:
250.7 Cr.
52-wk low:
110.3
52-wk high:
373

Is Indo US Bio-Tech Ltd an attractive stock to invest in?

1. Is Indo US Bio-Tech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Indo US Bio-Tech Ltd is a average quality company.

2. Is Indo US Bio-Tech Ltd undervalued or overvalued?

The key valuation ratios of Indo US Bio-Tech Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Indo US Bio-Tech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Indo US Bio-Tech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Indo US Bio-Tech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indo US Bio-Tech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.4%14.2%27.8%20.4%16.7%18.3%15.9%14.6%14.4%21.2%-
Value Creation
Index
-0.50.01.00.50.20.30.10.00.00.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 19.124.529.635.539.840.150.161.772.8104119
Sales YoY Gr.-28.7%20.9%19.8%12%0.8%24.8%23.4%18%42.6%-
Adj EPS 0.40.41.51.51.83.52.93.64.18.18.4
YoY Gr.-11.4%292.3%-1.3%15.9%100%-18.3%26.2%14.1%96.8%-
BVPS (₹) 3.23.44.89.511.314.821.227.231.339.243.2
Adj Net
Profit
0.40.41.62.22.65.15.27.28.316.317
Cash Flow from Ops. -2.60.1-0.9-3.2-0.80.22.90.5-4.61.4-
Debt/CF from Ops. -1.871.5-7.4-2-10.2514.322.1-3.110.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 20.7%21.2%27.5%42.6%
Adj EPS 41.8%35.9%41.5%96.8%
BVPS32.2%28.3%22.7%25.2%
Share Price - 47.5% 20.9% -65.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
11.711.737.223.316.826.917.315.514.12320.5
Op. Profit
Mgn %
2.75.19.710.11013.813.915.214.818.216.7
Net Profit
Mgn %
1.91.65.36.26.412.710.511.711.315.714.3
Debt to
Equity
1.41.41.30.50.50.50.30.20.20.20
Working Cap
Days
173170161188243322314317331279136
Cash Conv.
Cycle
8484102146173214255271295265104

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 20.50%

Sales growth is growing at healthy rate in last 3 years 27.54%

Net Profit is growing at healthy rate in last 3 years 41.54%

Sales growth is good in last 4 quarters at 45.46%

No data to display

Latest Financials - Indo US Bio-Tech Ltd.

Standalone Consolidated
TTM EPS (₹) 8.4 2.5
TTM Sales (₹ Cr.) 119 50.1
BVPS (₹.) 43.2 0
Reserves (₹ Cr.) 67 29
P/BV 2.89 0.00
PE 14.84 49.50
From the Market
52 Week Low / High (₹) 110.30 / 373.00
All Time Low / High (₹) 12.85 / 386.00
Market Cap (₹ Cr.) 251
Equity (₹ Cr.) 20.1
Face Value (₹) 10
Industry PE 29.6

Management X-Ray of Indo US Bio-Tech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Indo US Bio-Tech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Indo US Bio-Tech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales192530354040506273104
Operating Expenses 19232732363543526285
Manufacturing Costs1027292948467779
Material Costs1720232240-92-202
Employee Cost 0000000111
Other Costs 1222254334
Operating Profit 113346791119
Operating Profit Margin (%) 2.7%5.1%9.1%9.6%10.0%13.8%13.8%15.2%14.8%18.2%
Other Income 0000000000
Interest 0110111121
Depreciation 0000000111
Exceptional Items 000-0-000000
Profit Before Tax 01233457917
Tax -00110-10010
Profit After Tax 00123557816
PAT Margin (%) 1.9%1.6%4.9%5.9%6.4%12.7%10.5%11.7%11.3%15.7%
Adjusted EPS (₹)0.40.41.41.41.73.52.93.64.18.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%3%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 33514162239546379
Share Capital 1135669102020
Reserves 2229101530444358
Minority Interest0000000000
Debt556581110101313
Long Term Debt0011133233
Short Term Debt445577781010
Trade Payables5452892141
Others Liabilities -0012224334
Total Liabilities 13121724354355698497

Fixed Assets

Gross Block22231267715
Accumulated Depreciation1101000004
Net Fixed Assets 11211267710
CWIP 0001122140
Investments 0000000000
Inventories5561191223275271
Trade Receivables6599212521251915
Cash Equivalents 0000000010
Others Assets 1101223811
Total Assets 13121724354355698497

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -30-1-3-1031-51
PBT 01233457917
Adjustment 0011112223
Changes in Working Capital -3-1-3-7-5-5-4-9-15-18
Tax Paid -0-0-0-0-0-0-0-0-0-0
Cash Flow From Investing Activity -0-00-3-1-2-5-74-1
Capex -0-0-0-1-0-2-4-2-3-1
Net Investments 00000-00000
Others 001-1-00-1-570
Cash Flow From Financing Activity 301621261-1
Net Proceeds from Shares 0007003800
Net Proceeds from Borrowing -001-1-030-210
Interest Paid -0-0-1-0-1-1-1-1-2-1
Dividend Paid 000000-000-1
Others 300-0301120
Net Cash Flow 0-0000-0-001-1

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.6911.7434.3622.2116.7426.8717.3415.5114.0823.03
ROCE (%)7.3914.2427.8420.3516.6518.315.8614.6214.4221.15
Asset Turnover Ratio1.881.952.051.741.361.031.0210.951.15
PAT to CFO Conversion(x)N/AN/A-1-1.5-0.3300.60.14-0.630.06
Working Capital Days
Receivable Days6679879313820816513411060
Inventory Days917870879196128149197215
Payable Days867964544180-223302-54598

Indo US Bio-Tech Ltd Stock News

Indo US Bio-Tech Ltd FAQs

The current trading price of Indo US Bio-Tech on 18-Dec-2025 16:59 is ₹119.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Dec-2025 the market cap of Indo US Bio-Tech stood at ₹250.7.
The latest P/E ratio of Indo US Bio-Tech as of 17-Dec-2025 is 14.84.
The latest P/B ratio of Indo US Bio-Tech as of 17-Dec-2025 is 2.89.
The 52-week high of Indo US Bio-Tech is ₹373.0 and the 52-week low is ₹110.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indo US Bio-Tech is ₹118.6 ( Cr.) .

About Indo US Bio-Tech Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×